Samarra Pharmaceuticals Company Signs An Investment Contract With An Emirati Company To Establish Two New Medical Gas Production Lines

Baghdad The General Company for the Pharmaceutical Industry and Medical Supplies in Samarra (SDI) , one of the companies of the Ministry of Industry and Minerals, announced the conclusion of an investment contract with an Emirati company to establish two new lines for the production of medical gases.

According to a statement by the Ministry of Industry and Minerals, Khaled Mohi, the company’s assistant director general for chemical plant affairs, indicated that an investment contract was concluded with the Emirates Al-Waqia Company to establish two new lines in the Baghdad Medical Gas Factory, the first specialized in the production of nitrous oxide gas (anesthetic gas) for surgical operations and which has been suspended since 2003, as it is considered one of the only important production lines in the country and the second for the production of medical oxygen to raise the production capacity of the factory to (2,500) liters per day and to continue to meet the needs of the Iraqi Ministry of Health and hospitals of medical oxygen.

The Assistant Director-General announced the imminent completion of the rehabilitation work of the intravenous solutions factory in Nineveh, in cooperation with the United Nations Development Programme (UNDP), in preparation for its operation after it stopped working due to the destruction caused by terrorism, pointing to the company’s future plan to add new production lines of other medical supplies to cover the need of the Ministry of Health.”

Source: National Iraqi News Agency